CME Information
This activity is jointly provided by Global Education Group (Global) and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC), in collaboration with Kidney Disease: Improving Global Outcomes (KDIGO).
Acknowledgement
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
Credits Available
- Physicians — maximum of 1.25 AMA PRA Category 1 Credit(s)™
All other healthcare professionals completing this course will be issued a statement of participation.
Date of Release/Expiration
This activity was released on December 11, 2025, and is valid until December 11, 2026. Requests for credit must be made no later than December 11, 2026.
Target Audience
The educational design of this activity addresses the needs of primary care providers, nephrologists, renal pathologists, transplant nephrologists, nephrology nurses, nephrology nurse practitioners and physician associates, specialty pharmacists, and managed care clinicians.
Program Overview
Stay ahead of the latest advances in treatment for immunoglobulin A nephropathy (IgAN). Join experts in primary care and nephrology for this on-demand CME activity that highlights new KDIGO guideline recommendations, explains the critical role of proteinuria control, and identifies the place of newly approved therapies in treatment. Learn practical, evidence-based strategies for diagnosis and management to improve renal outcomes in patients with IgAN.
Learning Objectives
After completing this activity, the participant should be better able to:
- Summarize the long-term prognosis and potential complications for patients with IgA nephropathy
- Explain the rationale for sustained proteinuria reduction as a goal of IgAN management, based on the impacts of proteinuria on disease progression and risk of transplantation
- Develop strategies to apply KDIGO’s recommendations on the role of newly approved agents for IgAN in addressing drivers of and generic response to nephron loss
- Summarize the latest understanding of pathophysiologic pathways leading to IgAN, including complement activation and proteinuria regulation and implications for management to further reduce proteinuria
Faculty
Neil Skolnik, MD
Professor of Family and Community Medicine
Sidney Kimmel Medical College
Thomas Jefferson University
Associate Director
Family Medicine Residency Program
Jefferson Health - Abington
Jai Radhakrishnan, MD, MS
Professor of Medicine, Columbia University Medical Center
Clinical Director, Division of Nephrology
Columbia University Vagelos College of Physicians and Surgeons
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC). Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Estimated Time To Complete
This activity should take approximately 75 minutes to complete.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a score of 70% on the post-test.
Hardware/Software Requirements
Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
Disclosures of Relevant Financial Relationships
Global adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous. All persons in a position to control the content of an accredited continuing education program provided by Global are required to disclose all financial relationships with any ineligible company within the past 24 months to Global. All financial relationships reported are identified as relevant and mitigated by Global in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of this activity was vetted by Global to assure objectivity and that the activity is free of commercial bias.
All relevant financial relationships have been mitigated.
The faculty have the following relevant financial relationships with ineligible companies:
The planners and managers at Global Education Group and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC) have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and MedliveCME, LLC (previously known as PlatformQ Health Education, LLC) do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Contact Information
Accreditation Support:
For information about the accreditation of this program, please contact Global at 303-395-1782 or [email protected].
Technical Support:
For any technical issues or issues with your CME Certificate, please contact Medlive at 877-394-1306 or at [email protected].